Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROFID EHRA
NCT05665608Recruiting
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Nov 2023
- Primary completion
- Nov 2027
- Countries
- 13
01
Overview
Randomised, open-label trial in myocardial infarction (MI), heart failure (HF) and sudden cardiac death (SCD) (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: All-Cause Mortality. Started Nov 2023; status: recruiting.
02
Conditions
myocardial infarction (MI)heart failure (HF)sudden cardiac death (SCD)
Beyond the preview
Go deeper on NCT05665608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05665608.